Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection

Alissa Visram, Dirk Larson, Aaron D Norman, Angela Dispenzieri, David L Murray, Robert A Kyle, S. Vincent Rajkumar, Susan L. Slager, Shaji K Kumar, Celine M. Vachon

Blood blood.2024025415.

https://doi.org/10.1182/blood.2024025415

Published: 2024

Includes: Supplemental data

Journal Articles

Comparison of MGUS Prevalence By Race and Family History Risk Groups Using a High Sensitivity Screening Method (MASS-FIX)

Celine M. Vachon, PhD, Josiah Murray, Cristine Allmer, BS, Dirk Larson, MS, Aaron D. Norman, MPH, Jason P Sinnwell, MS, Angela Dispenzieri, MD, Geffen Kleinstern, PhD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Susan L. Slager, PhD, Shaji K. Kumar, MD, David L. Murray, MDPhD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-142583

Published: 2020

Journal Articles

Body Mass Index and Clinical Factors Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) Progression in Olmsted County, Minnesota

Geffen Kleinstern, PhD, Dirk Larson, MS, Cristine Allmer, BS, Aaron D. Norman, MPH, Jason P Sinnwell, MS, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Robert A. Kyle, MD, Susan L. Slager, PhD, Shaji K. Kumar, MD, Celine M. Vachon, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-136894

Published: 2020

Journal Articles

Comparative Analysis of Staging Systems in AL Amyloidosis

Blood (2018) 132 (Supplement 1): 3228.

https://doi.org/10.1182/blood-2018-99-114262

Published: 2018

Journal Articles

Genomic Abnormalities Among African Individuals with Monoclonal Gammopathies Using Calculated Ancestry

Linda B Baughn, PhD, Dirk Larson, MS, Mei-Yin Polley, PhD, Kathryn E. Pearce, Eran Elhaik, PhD, Michael L. Baird, PhD, Colin Colby, Joanne Benson, Zhou Li, MS, Yan Asmann, PhD, Terry Therneau, PhD, James R. Cerhan, MD PhD, Celine M. Vachon, PhD, A Keith Stewart, MB, ChB, P. Leif Bergsagel, MD, Angela Dispenzieri, MD, Shaji K. Kumar, MD, S. Vincent Rajkumar, MD

Blood (2018) 132 (Supplement 1): 4458.

https://doi.org/10.1182/blood-2018-99-117382

Published: 2018

Journal Articles

Progression and Outcome in Patients with Biclonal Gammopathies

Trey Carlton Mullikin, BS, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Morie A Gertz, MD, Martha Q Lacy, MD, Francis Buadi, MD, Prashant Kapoor, MD, Jerry A. Katzmann, PhD, Dirk Larson, Robert Kyle, MD MACP, Shaji Kumar, MD

Blood (2014) 124 (21): 5699.

https://doi.org/10.1182/blood.V124.21.5699.5699

Published: 2014

Journal Articles

Development Of Solid Malignancies In Patients With Monoclonal Gammopathy Of Undetermined Significance (MGUS): A Population-Based Study Of 17,315 Patients

Lindsey E. Roeker, Dirk Larson, Robert Kyle, MD, MACP, Shaji K Kumar, MD, Angela Dispenzieri, MD, Vincent Rajkumar, MD

Blood (2013) 122 (21): 3134.

https://doi.org/10.1182/blood.V122.21.3134.3134

Published: 2013

Journal Articles

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

Angela Baker, Esteban Braggio, Susanna Jacobus, Sungwon Jung, Dirk Larson, Terry Therneau, Angela Dispenzieri, Scott A. Van Wier, Gregory Ahmann, Joan Levy, Louise Perkins, Seungchan Kim, Kimberly Henderson, David Vesole, S. Vincent Rajkumar, Diane F. Jelinek, John Carpten, Rafael Fonseca

Blood (2013) 121 (16): 3147–3152.

https://doi.org/10.1182/blood-2012-07-443606

Published: 2013

Includes: Supplemental data

Journal Articles

Idiopathic Bence Jones Proteinuria (Smoldering Monoclonal Light-Chain Proteinuria): Clinical Course and Prognosis

Robert A. Kyle, MD, Dirk Larson, Terry M Therneau, PhD, Angela Dispenzieri, MD, Joanne T Benson, L. Joseph Melton, III, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 1861.

https://doi.org/10.1182/blood.V120.21.1861.1861

Published: 2012

Journal Articles

Development of Myelodysplastic Syndrome and Acute Leukemias in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study of 17,315 Patients

Lindsey E. Roeker, Dirk Larson, Robert A. Kyle, MD, Shaji K. Kumar, MD, Angela Dispenzieri, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 934.

https://doi.org/10.1182/blood.V120.21.934.934

Published: 2012

Journal Articles

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

Shaji K. Kumar, MD, Angela Dispenzieri, MD, Morie A Gertz, Martha Q Lacy, MD, John A Lust, MD, PhD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Stephen Russell, MD, PhD, Prashant Kapoor, MD, Yi Lin, MD, PhD, Lisa Hwa, RN, CNP, Dirk Larson, Colin L. Colby, Joanne T Benson, Robert A. Kyle, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 3972.

https://doi.org/10.1182/blood.V120.21.3972.3972

Published: 2012

Journal Articles

Differences in the Distribution of Cytogenetic Subtypes Between Multiple Myeloma Patients with and without a History of Familial MGUS and Multiple Myeloma

Alexandra Greenberg, Margot Cousin, Celine M Vachon, PhD, Dirk Larson, Colin L. Colby, Shaji K. Kumar, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 4000.

https://doi.org/10.1182/blood.V120.21.4000.4000

Published: 2012

Journal Articles

Treatment Patterns and Outcomes in Elderly Patients with Multiple Myeloma,

Soo-Mee Bang, Robert A Kyle, MD, Jae Hoon Lee, MD, Angela Dispenzieri, MD, Dirk Larson, Colin L. Colby, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2011) 118 (21): 3980.

https://doi.org/10.1182/blood.V118.21.3980.3980

Published: 2011

Journal Articles

Non-Clonal Serum Immunoglobulin Free Light Chains (FLC) as Markers of Overall Survival

Angela Dispenzieri, M.D., Robert Kyle, MD, Jerry A Katzmann, PhD, Dirk Larson, Shaji Kumar, MD, Graham Peter Mead, PhD, Arthur Bradwell, FRCP, FRCPath, S. Vincent Rajkumar, MD

Blood (2010) 116 (21): 3893.

https://doi.org/10.1182/blood.V116.21.3893.3893

Published: 2010

Journal Articles

Increased Incidence of Extramedullary Plasmacytomas In Patients with Multiple Myeloma In the Era of Novel Therapy and Effect of Pomalidomide on Extramedullary Disease

Kristen Detweiler Short, RN, CNP, S. Vincent Rajkumar, MD, Francis Buadi, MD, Dirk Larson, Suzanne R. Hayman, MD, Angela Dispenzieri, MD, Morie Abraham A Gertz, MD, Shaji Kumar, MD, Joseph R. Mikhael, MD, Vivek Roy, Robert Kyle, MD, Martha Lacy, MD

Blood (2010) 116 (21): 3047.

https://doi.org/10.1182/blood.V116.21.3047.3047

Published: 2010

Journal Articles

Serum Immunoglobulin Free Light Chain in Primary Amyloidosis: Prognostic Value and Correlations with Clinical Features

Shaji Kumar, MD, Angela Dispenzieri, Raynell Clark, Dirk Larson, Colin Colby, Steve Zeldenrust, Martha Lacy, Suzzane Hayman, Francis Buadi, Nelson Leung, Marina Ramirez-Alvarado, Robert Kyle, Jerry Katzmann, S. Vincent Rajkumar, Morie Gertz

Blood (2008) 112 (11): 2733.

https://doi.org/10.1182/blood.V112.11.2733.2733

Published: 2008

Journal Articles

Normalization of the Serum Free Light Chain (FLC) Ratio Is Associated with Superior Overall Survival among Myeloma Patients Achieving Immunofixation Negative State: Results Support Incorporation of Serum FLC Ratio in Stringent CR Definition.

Shaji Kumar, MD, Angela Dispenzieri, Dirk Larson, Colin Colby, Robert Kyle, Morie Gertz, S.Vincent Rajkumar

Blood (2008) 112 (11): 1692.

https://doi.org/10.1182/blood.V112.11.1692.1692

Published: 2008

Journal Articles

Clinical Course and Prognosis of Smoldering (Asymptomatic) Waldenstrom’s Macroglobulinemia

Robert Kyle, MD, Joanne Benson, BA, Dirk Larson, MS, Terry Therneau, PhD, Angela Dispenzieri, MD, L. Joseph Melton, III, MD, S. Vincent Rajkumar

Blood (2008) 112 (11): 2709.

https://doi.org/10.1182/blood.V112.11.2709.2709

Published: 2008

Journal Articles

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Angela Dispenzieri, Robert A. Kyle, Jerry A. Katzmann, Terry M. Therneau, Dirk Larson, Joanne Benson, Raynell J. Clark, L. Joseph Melton, III, Morie A. Gertz, Shaji K. Kumar, Rafael Fonseca, Diane F. Jelinek, S. Vincent Rajkumar

Blood (2008) 111 (2): 785–789.

https://doi.org/10.1182/blood-2007-08-108357

Published: 2008

Journal Articles

Immunoglobulin Free Light Chain Ratio Is an Independent Risk Factor for Progression of Smoldering Multiple Myeloma.

Angela Dispenzieri, MD, Robert A. Kyle, M.D., Jerry A. Katzmann, Ph.D., Dirk Larson, Joanne Benson, Raynell Clark, L. Joseph Melton, Ph.D., Morie A. Gertz, M.D., Shaji K. Kumar, M.D, Rafael Fonseca, M.D., Diane F. Jelinek, Ph.D, S. Vincent Rajkumar, M.D.

Blood (2007) 110 (11): 1487.

https://doi.org/10.1182/blood.V110.11.1487.1487

Published: 2007

NARROW

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection

Comparison of MGUS Prevalence By Race and Family History Risk Groups Using a High Sensitivity Screening Method (MASS-FIX)

Body Mass Index and Clinical Factors Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) Progression in Olmsted County, Minnesota

Comparative Analysis of Staging Systems in AL Amyloidosis

Genomic Abnormalities Among African Individuals with Monoclonal Gammopathies Using Calculated Ancestry

Progression and Outcome in Patients with Biclonal Gammopathies

Development Of Solid Malignancies In Patients With Monoclonal Gammopathy Of Undetermined Significance (MGUS): A Population-Based Study Of 17,315 Patients

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

Idiopathic Bence Jones Proteinuria (Smoldering Monoclonal Light-Chain Proteinuria): Clinical Course and Prognosis

Development of Myelodysplastic Syndrome and Acute Leukemias in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study of 17,315 Patients

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

Differences in the Distribution of Cytogenetic Subtypes Between Multiple Myeloma Patients with and without a History of Familial MGUS and Multiple Myeloma

Treatment Patterns and Outcomes in Elderly Patients with Multiple Myeloma,

Non-Clonal Serum Immunoglobulin Free Light Chains (FLC) as Markers of Overall Survival

Increased Incidence of Extramedullary Plasmacytomas In Patients with Multiple Myeloma In the Era of Novel Therapy and Effect of Pomalidomide on Extramedullary Disease

Serum Immunoglobulin Free Light Chain in Primary Amyloidosis: Prognostic Value and Correlations with Clinical Features

Normalization of the Serum Free Light Chain (FLC) Ratio Is Associated with Superior Overall Survival among Myeloma Patients Achieving Immunofixation Negative State: Results Support Incorporation of Serum FLC Ratio in Stringent CR Definition.

Clinical Course and Prognosis of Smoldering (Asymptomatic) Waldenstrom’s Macroglobulinemia

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Immunoglobulin Free Light Chain Ratio Is an Independent Risk Factor for Progression of Smoldering Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only